invest definition

Source: Stock Photo

The first thing to understand about Energen (NYSE:EGN) it has the capability and will to increase production steadily over the next three years, even if oil were to remain at about $50 per barrel. As it stands, the company believes should be able to double output by the end of 2019.

By the end of 2017 the company guides for production jump to about 65.7 MBOE per day, and by 2019 to reach 100,000 BOE per day. In 4Q16, production was at 53.5 MBOE per day.

When considering the implications of the recent well completion of EOG Resources (NYSE:EOG), suggesting resource and reserves in the play could be much higher than believed – of which Energen has a lot of exposure – the long-term outlook for the company appears to be even better than it already was.

invest definition: Alexco Resource Corp(AXU)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Alexco Resource (NYSEMKT: AXU) operates in two segments: an environmental services business and a mining company. Its mining segment explores developments in Canada, while its environmental segment provides consulting and project management services in the United States and Canada. AXU is up over 400% YTD. The stock has been steadily rising since January. It isn’t clear what’s driving AXU upwards, other than general investor speculation. The stock is trading at $1.72 per share as of Monday intraday.

invest definition: OSI Systems, Inc.(OSIS)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap homeland security and screening stocks like FLIR Systems (NASDAQ: FLIR), OSI Systems (NASDAQ: OSIS),Varex Imaging Corp (NASDAQ: VREX) and Patriot One Technologies (OTCQB: PTOTF) stand to benefit fromTrumps focus on border andinternal security in general. Heres what you need to know about all four:

  • [By Paul Ausick]

    OSI Systems Inc. (NASDAQ: OSIS) dropped 36% Wednesday to post a new 52-week low of $53.80 after closing at $84.07 on Tuesday. The 52-week high is $96.64. Volume was around 9 million, around 6 times the daily average of about 155,000. Short seller Muddy Waters called OSI “rotten to the core” in a new report this morning.

  • [By Bryan Murphy]

    Look out OSI Systems, Inc. (NASDAQ:OSIS), and step aside American Science & Engineering, Inc. (NASDAQ:ASEI). You may be the key names in weapons detection and security screening right now, but an up-and-comer called Patriot One Technologies Inc. (CVE:PAT, OTCMKTS:PTOTF) is about to unleash a rival product that turns heads, and steals your customers.

    Weapons detection tools in a world that’s always got terrorism threats lurking around every corner are no laughing matter, though were it any other subject, the results would be laughable. See, as advanced as the x-ray and screening products made by American Science & Engineering and OSI Systems may be, they just don’t work well enough.

    Case in point: A recent internal investigation performed by the Transportation Security Administration (TSA) found that undercover investigators were able to smuggle fake explosives and weapons through checkpoints in 95% of trials, which they conducted at dozens of America’s busiest airports. What’s the point?

    For the past several years Patriot One Technologies has been working on a technology, called the CMR1000, that changes everything.

    The CMR1000 (‘CMR’ is an short for Cognitive Microwave Radar) is an amazing device. It works not unlike a X-ray machine at an airport, but also not unlike a more conventional metal detector you might find at an airport or at the entryway to a building. In all regards though, it’s better than both. By using high-frequency microwaves that are harmless to humans, the CMR1000 can even pinpoint exactly what kind of metallic weapon it is… a semi-automatic pistol versus a revolver, or a machete versus a pocket knife. Most important, the CMR1000 boasts a (very) high detection-accuracy rate of 93%.

    And it’s almost ready… ready enough to officially unveil this April at the ISC West (International Security Conference) in Las Vegas, and immediately begin taking orders for initial deliveries around the middle of

  • [By Bryan Murphy]

    If shareholders of OSI Systems, Inc. (NASDAQ:OSIS) and American Science & Engineering, Inc. (NASDAQ:ASEI) — makers of weapons detection systems — are getting a little nervous, that’s understandable. Never has either company’s share of the market been so threatened. Indeed, an up-and-coming company called Patriot One Technologies Inc. (CVE:PAT, OTCMKTS:PTOTF) fired another volley at American Science & Engineering and OSI Systems, announcing yet-another institution had asked for a real-life demonstration (on their premises) of the brand-new kind of anti-terrorism technology that Patriot One’s been developing for years.

    The CMR1000 (‘CMR’ is an short for Cognitive Microwave Radar) is nothing less than incredible. It works not unlike a X-ray machine at an airport, but also not unlike a more conventional metal detector you might find at an airport or at the entryway to a building. In all regards though, it’s better than both. By using high-frequency microwaves that are harmless to humans, the CMR1000 can even pinpoint exactly what kind of metallic weapon it is… a semi-automatic pistol versus a revolver, or a machete versus a pocket knife.

    This capability overcomes the key shortcoming of most threat-detection apparatus in use today…

    … which doesn’t work very well, by the way. A recent internal investigation performed by the Transportation Security Administration (TSA) found that undercover investigators were able to smuggle fake explosives and weapons through checkpoints in 95% of trials, which they conducted at dozens of America’s busiest airports.

    Patriot One Technologies is mostly excited about the launch of the CMR1000, however, because it’s not a mere threat-detection tool. Word will quickly spread that it’s a threat-deterrent tool; the easiest way combat violent action is not letting it happen in the first place, and the best way to do that to accurately find and accurately identify what the threat is, right down to

invest definition: (MALRF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

invest definition: GenMark Diagnostics, Inc.(GNMK)

Advisors’ Opinion:

  • [By Lisa Levin]

    GenMark Diagnostics, Inc (NASDAQ: GNMK) shares shot up 20 percent to $10.54. Cowen & Co. upgraded GenMark Diagnostics from Market Perform to Outperform.

invest definition: Straight Path Communications Inc.(STRP)

Advisors’ Opinion:

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

invest definition: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Sean Williams]

    Third, in late March, Mylan announced that the Food and Drug Administration had rejected its application to market a generic version of GlaxoSmithKline’s (NYSE:GSK) blockbuster asthma and COPD inhalable drug, Advair. GlaxoSmithKline’s Advair lost patent protection more than six years ago, but only within the past couple of years did the FDA lay out a course for generic drug producers to follow in order to get a generic version of the drug approved. Meanwhile, Glaxo still enjoys blockbuster sales of Advair as generic versions of the drug have yet to hit the market.

  • [By WWW.THESTREET.COM]

    Up first on our list of potentially toxic trades is $98 billion healthcare stock GlaxoSmithKline plc (GSK) . GSK has actually been an attractive name to own lately. Shares are up about 10.6% since bottoming back in December, besting the S&P over that timeframe. But if you own GlaxoSmithKline, now’s the time to start thinking about taking some of those recent gains off the table — shares are looking “toppy” this spring.

  • [By Keith Speights]

    There are several choices for investing in HIV drug stocks. Three of the best options for long-term investors are Gilead Sciences (NASDAQ:GILD), GlaxoSmithKline (NYSE:GSK), and Merck (NYSE:MRK). Here’s why these HIV drug stocks could be solid picks in 2017.

  • [By WWW.MONEYSHOW.COM]

    Two of our top holdings, GlaxoSmithKline (GSK) and Merck (MRK) have seen substantial improvement in earnings as new drugs start to build market share. Glaxo and Merck offer dividend yields of 4.71% and 3.08%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *